BAM
CORT icon

Bosun Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bosun Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,274
Closed -$1.19M – 101
2025
Q2 		$1.19M Buy
16,274
+8,413
+107% +$610K 0.36% 59
2025
Q1 		$898K Buy
7,861
+766
+11% +$46.6K 0.39% 63
2024
Q4 		$358K Buy
+7,095
New +$372K 0.16% 145

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bosun Asset Management's CORT Position: Q3 2025 in Review

Bosun Asset Management sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 16,274 shares — an estimated $1.19M sold.

Bosun Asset Management first reported a position in CORT in Q4 2024 and held it in 3 quarters. The position peaked at $1.19M in Q2 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Bosun Asset Management reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bosun Asset Management sold 16,274 Corcept Therapeutics shares in Q3 2025, an estimated $1.19M.
  • Bosun Asset Management first reported a position in Corcept Therapeutics in Q4 2024 and held it in 3 quarters.
  • Bosun Asset Management's Corcept Therapeutics position peaked at $1.19M in Q2 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Bosun Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.